Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiko Kubo is active.

Publication


Featured researches published by Yoshiko Kubo.


European Journal of Pharmacology | 1987

S-adenosyl-L-methionine prevents ischemic neuronal death

Yoshiki Matsui; Yoshiko Kubo; Nobuyoshi Iwata

The effect of S-adenosyl-L-methionine (SAM) on neuronal degeneration induced by transient forebrain ischemia was studied in rats. Bilateral occlusion of the common carotid arteries for 30 min in a 4-vessel occlusion model caused degeneration of CA1 neurons of the hippocampus. When SAM-HCl or SAM sulphate tosylate (SAM-ST, 100 mg/kg as the free form of SAM, i.p.) was administered just after recirculation and every hour for 5 h after recirculation, the degeneration and loss of pyramidal cells were prevented. However, adenosine, a metabolite of SAM, and glycerol, which has the same osmotic pressure as the solution of SAM-ST, did not show any effects on the neuronal damage. The results showed that SAM has a beneficial effect on neuronal damage induced by ischemia.


Archive | 1989

Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants

Mitsuo Nagano; Jun-ichi Sakai; Nobuyoshi Iwata; Kazuo Kobayashi; Masao Kozuka; Kenji Yoshimi; Katsunori Kato; Yoshiko Kubo; Toshiyuki Tonohiro; Takao Hara


Japanese Journal of Pharmacology | 1988

Effects of S-adenosyl-L-methionine upon ischemia-induced brain edema in Mongolian gerbils and spontaneously hypertensive rats.

Masao Kozuka; Yoshiko Kubo; Kazuo Kobayashi; Nobuyoshi Iwata


Archive | 1990

Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders

Hiroaki Yanagisawa; Koichi Fujimoto; Yasuo Shimoji; Takuro Kanazaki; Nobuyoshi Iwata; Yoshiko Kubo


Japanese Journal of Pharmacology | 1990

S-adenosyl-L-methionine ameliorates reduced local cerebral glucose utilization following brain ischemia in the rat.

Kazuo Kobayashi; Eiichi Nakajima; Yoshiko Kubo; Yoshie Yasukawa; Nobuyoshi Iwata


Archive | 1989

Use of isoxazolinones as cerebro-active drugs

Nobuyoshi Iwata; Kazuo Kobayashi; Yoshiko Kubo; Masao Kozuka; Mitsuo Nagano


Archive | 1992

Quinuclidinyloxy-isoxazole compounds and their therapeutic uses

Mitsuo Nagano; Takeo Kobayashi; Jun-ichi Sakai; Masao Kozuka; Nobuyoshi Iwata; Yoshiko Kubo


Archive | 1991

Piperdinyloxy- und Chinindidinyloxy- isoxazol- Derivate, ihre Herstellung und ihre therapeutische Verwendung. Piperdinyloxy- and Chinindidinyloxy- isoxazole derivatives, their preparation and their therapeutic use.

Mitsuo Nagano; Jun-ichi Sakai; Takeo Kobayashi; Masao Kozuka; Nobuyoshi Iwata; Yoshiko Kubo


Archive | 1991

Piperidyloxy- and quinuclidinyloxyisoxazolderivater, their preparation and their therapeutic use

Mitsuo Nagano; Jun-ichi Sakai; Takeo Kobayashi; Masao Kozuka; Nobuyoshi Iwata; Yoshiko Kubo


Archive | 1991

Piperidiloxiisoxazol and quinuclidiniloxiisoxazol derivatives, their preparation and their therapeutic use.

Mitsuo C O Sankyo Compa Nagano; Jun-ichi Sakai; Takeo Kobayashi; Masao Kozuka; Nobuyoshi Iwata; Yoshiko Kubo

Collaboration


Dive into the Yoshiko Kubo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazuo Kobayashi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenji Yoshimi

University of Southern California

View shared research outputs
Researchain Logo
Decentralizing Knowledge